Recipients are selected for their contributions to the fields of bone marrow failure disease treatment and/or research. Nominees are considered for their impact on patients and families affected by aplastic anemia, MDS and PNH, and/or their contributions through research to increasing knowledge and understanding about these diseases. Additional consideration is given to those who have demonstrated a commitment to AA&MDSIF.
Dr. Santini leads the MDS program in the Hematology Unit at the Azienda Ospedaliero Universitaria Careggi Medical School, University of Florence. She was recognized for her scientific interests and publications focused on maturation induction and therapeutic targeting of epigenetics modifications, myeloid leukemias, and
A long‐time friend of AA&MDSIF, Dr. Deeg brings a beacon of hope for patients and their families facing MDS through his research and his personal care, Highly regarded for his outstanding contributions as a researcher and clinician, Dr. Deeg specializes in treating blood disorders, bone marrow transplant, leukemia and myelodyplastic syndromes (MDS).
Dr. Young's research interests are in human hematopoiesis,
Dr. Stone cares for patients with acute and chronic leukemias, myelodysplasia and myeloproliferative disorders. Dr. Stone conducts clinical and translational research with the goal of deriving better outcomes for patients with these disorders. His laboratory research focuses on the mechanism of leukemic cell differentiation, with the ultimate goal of producing new cancer therapies.